A cytoskeletal protein called vimentin helps prevent the nuclei of cells that must navigate through tight spaces in the body from rupturing, according to a recent study.
Browsing: Will Doss
A unified vision for health equity in Chicago was the focus of the second IPHAM Population Health Forum, where scientists and community partners presented and discussed their work in a variety of areas.
Feinberg has had an exceptional year of scientific inquiry, ranging from examining the most basic systems that make our bodies tick to developing breakthrough therapies and treatment strategies.
Feinberg’s new Institute for Global Health hosted its inaugural Global Health Day symposium, a day-long event that featured presentations from each of the institute’s constituent Centers, a poster session, several panels and keynote speakers.
A new machine-learning tool demonstrates the clinical potential of ‘junk DNA’ methylation in hepatitis C-associated liver cancer patients without the need for expensive testing.
A one-of-a-kind drug created to treat a single patient passed a crucial test at Northwestern, according to a study published in the New England Journal of Medicine.
Northwestern scientists have developed a battery-free, wireless device for studying brain function using a combination of light and drugs, publishing their design in PNAS.
A study published in the Journal of Cell Biology showed that mitochondrial stress in neurons can cause an enzyme imbalance that contributes to neuronal dysfunction and death.
Faculty, staff, students and trainees gathered for the ninth annual Les Turner Symposium on ALS and NeuroRepair, a one-day event highlighting the present and future of treating ALS.
A new review has found that a combination of endocrine inhibitors and hormone therapy is more effective in prolonging progression-free survival for advanced breast cancer patients, as compared to chemotherapy.